COMMUNIQUÉS West-GlobeNewswire

Bellwyck Pharma Services on Growth Path
14/06/2019
Expands Cold Storage Space in U.S., Adds Packaging Services in EU BURLINGTON, Ontario, June 14, 2019 (GLOBE NEWSWIRE) -- Bellwyck Pharma Services, a leader in primary and secondary packaging and labeling for the [...]
New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients With Liver Fibrosis
14/06/2019
NASH Development Strategy for tesamorelin to be Unveiled on June 17, 2019 MONTREAL, June 14, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce additional data from the [...]
De nouvelles données divulguées par Theratechnologies démontrent l’impact positif de la tésamoréline sur les patients présentant une fibrose du foie
14/06/2019
La stratégie de développement de la tésamoréline pour le NASH sera dévoilée le 17 juin 2019 MONTRÉAL, 14 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer de [...]
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
14/06/2019
RESEARCH TRIANGLE PARK, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that an analysis of patient-reported outcomes (PRO) data from [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. [...]
Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)
14/06/2019
SAN DIEGO, June 14, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announces today that senior management will be presenting in the upcoming JMP Life Sciences Conference in New York City [...]
Tauriga Sciences, Inc. Incorporates Private Limited Company in Belfast, Northern Ireland
14/06/2019
NEW YORK, NY, June 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association
14/06/2019
– CG-806 safely and durably suppressed tumor growth in preclinical models – SAN DIEGO and TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a [...]
Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma
14/06/2019
– Primary endpoint achieved with 45% and 42% ORR in AITL and CXCL12+ AITL/PTCL-NOS expansion cohorts – – PTCL patients with tumors characterized by high CXCL12/CXCR4 expression ratio experienced an ORR of 47% and a [...]
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
14/06/2019
RANCHO CUCAMONGA, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, will be presenting at the Raymond James Life Sciences and MedTech [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
14/06/2019
Company announcement – No. 22 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, June 14, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 [...]
TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
14/06/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 14, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early
14/06/2019
LONDON, June 14, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of s [...]
Philips Research wins Dutch Hendrik Lorentz Award for its pioneering use of data science and artificial intelligence in healthcare
14/06/2019
June 14, 2019 Philips’ AI-powered adaptive intelligence solutions help people to live healthy lifestyles, improve patient outcomes, reduce healthcare costs, and enhance the patient and staff experience Amsterdam, the [...]
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
14/06/2019
Amsterdam, The Netherlands – 14 June 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) is pleased to announce that it has agreed an extension of the maturity dates for EUR 4,750,000 in unsecured convertible loan notes ( [...]
GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor
14/06/2019
Data Supporting the Potential of Voxelotor as a Disease-Modifying Treatment for Sickle Cell Disease (SCD) Published in The New England Journal of Medicine and to be Presented During Presidential Symposium at the 24 th [...]
Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)
14/06/2019
Results from two Phase II trials, ENESTfreedom and ENESTop, support and extend previous findings of long-term durability of molecular response after stopping Tasigna, reducing time on drug for many CML patients 1,2 New [...]
BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA)
14/06/2019
First Preliminary Data from Exploratory MYD88 WT Patient Cohort in Phase 3 Trial in Waldenström’s Macroglobulinemia (WM) ; Updated Phase 1/2 WM Data; and Pooled Safety Data Analysis on Zanubrutinib in B-Cell [...]

Pages